(Q50982750)

26 March 2018

title

Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer? (English)

1 reference

26 March 2018

main subject

endometrial carcinoma

1 reference

Meral Koyuncuoglu

1

1 reference

26 March 2018

Emre Okyay

2

1 reference

26 March 2018

Bahadir Saatli

3

1 reference

26 March 2018

Safak Olgan

4

1 reference

26 March 2018

Mustafa Akin

5

1 reference

26 March 2018

Ugur Saygili

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

22 December 2011

1 reference

26 March 2018

published in

Gynecologic Oncology

1 reference

26 March 2018

volume

125

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

208-213

1 reference

26 March 2018

Prognostic parameters of endometrial carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Two pathogenetic types of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumor budding as a prognostic marker in laryngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Prognostic value of tumor "budding" in patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Role of E‐cadherins in development of lymphatic tumor emboli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumour budding in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumor dedifferentiation: an important step in tumor invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Loss of membranous Ep-CAM in budding colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumour budding correlates with local recurrence of rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Tumour budding as prognostic factor in stage I/II colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Molecular mechanisms controlling E-cadherin expression in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.12.433

10.1016/J.YGYNO.2011.12.433

7 January 2021

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018